Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

CHU de Rennes

CHU de Rennes in Rennes, France is listed as a site for 260 registered clinical trials, 74 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 260
Ongoing 74

This page covers the site record CHU de Rennes in Rennes, France: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled.

Get the CHU de Rennes report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 260 trials counted.

  • Phase 1 1 trial
  • Phase 1/2 3 trials
  • Phase 2 24 trials
  • Phase 2/3 3 trials
  • Phase 3 31 trials
  • Phase 4 8 trials
  • Not applicable 75 trials
  • Observational 114 trials
  • Expanded access 1 trial

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 74 trials
  • Completed 142 trials
  • Terminated 16 trials
  • Other 28 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 28

2006: 1 trials (Phase 4 1) 2007: 3 trials (Not applicable 1, Phase 4 1, Phase 3 1) 2008: 6 trials (Observational 1, Not applicable 1, Phase 3 3, Phase 1/2 1) 2009: 1 trials (Observational 1) 2010: 4 trials (Not applicable 2, Phase 3 1, Phase 2 1) 2011: 3 trials (Not applicable 2, Phase 2 1) 2012: 7 trials (Observational 2, Not applicable 3, Phase 3 2) 2013: 10 trials (Observational 5, Not applicable 1, Phase 4 2, Phase 3 2) 2014: 10 trials (Observational 6, Not applicable 1, Phase 3 1, Phase 2 2) 2015: 19 trials (Observational 9, Not applicable 5, Phase 4 1, Phase 3 1, Phase 2 2, Phase 1/2 1) 2016: 23 trials (Observational 13, Not applicable 5, Phase 2 4, Phase 1/2 1) 2017: 21 trials (Observational 11, Not applicable 6, Phase 4 1, Phase 3 3) 2018: 28 trials (Observational 14, Not applicable 5, Phase 3 5, Phase 2/3 1, Phase 2 3) 2019: 16 trials (Observational 8, Not applicable 6, Phase 3 1, Phase 2/3 1) 2020: 16 trials (Observational 8, Not applicable 4, Phase 3 2, Phase 2 2) 2021: 21 trials (Observational 11, Not applicable 6, Phase 3 2, Phase 2 2) 2022: 16 trials (Observational 8, Not applicable 4, Phase 3 1, Phase 2 2, Phase 1 1) 2023: 19 trials (Observational 7, Not applicable 9, Phase 4 1, Phase 2/3 1, Phase 2 1) 2024: 13 trials (Observational 3, Not applicable 6, Phase 3 4) 2025: 6 trials (Observational 2, Not applicable 3, Phase 4 1)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 14
2025 6
2024 13
2023 19
2022 16
2021 21
2020 16
2019 16
2018 28
2017 21

2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Conditions studied

The specific conditions of the trials that list this site, most trials first.